genetic traits have been analysed in inbred mouse populations, anc recently mouse models of complex genetic disease :e.g. IDDM) are being genetically dissected (Wichr LS et 01. J Exp Med 1987; 165, 1639-54) . Positi:.mal cloning of identified candidate susceptibility loci requires many polymorphic markers between relativdy similar inbred mouse strains. Therefore, the w,e of conventional techniques such as restriction length of fragment polymorphisms (RFLPs) need to be suppkmented with alternative approaches (Knight AM & Dyson PJ. Mol Cell Probes 1990; 4, 497-504) . We have successfully exploited the presence of single nucleotide repeats (microsatellites) in the mouse genome to establish a panel of nearly 200 polymorphic markers (Love JM et 01.Nuclei Acids Res 1990; 18, 4123-30; Hearne CM et 01. Mammalian Genome 1992; 1,273-82) that are currently being used in a number of genetic studies (Todd JA et al. Nature 1991; 351, 542-'1; Dyson PJ et 01. Nature 1991; 349, 531-2) . These sequences are highly polymorphic (approximately 35-60% between individual strain combinations) anq use of the polymerase chain reaction to amrlify them from genomic DNA also means they are extremely easy to use. Laboratory mice were once wild mice R J BERRY Department of Biology, University College London, Gower Street, London WC] 6BT, UK Almost all the '(lid' inbred strains of mice are derived from mice caugh: in the wild in the USA, many of them supplied by Abbe Lathrop of Granby, Massachusetts. It is uncertain how much f)f the genome of such standard strains as DBA, C5',BL, etc., is derived from feral mice sensu stricto, and how much domesticated mice used as pets or for showing (such as 'Japanese waltzing mice'). However, there can be no doubt that most of the genes in laboratory mice come from a rather limited p )rtion of the variation present in the wild (although most enzyme variants found in the wild have also been reported in unbred strains).
In the laborawry it is difficult to know the consequencefor the animal of much variation (except for overtly pathogenic alleles). In fact many variants have been shown to be affected by first or second order natural selection. Significant genetic changes (which must be due to selection) have been found in studies on British mouse populations, on sub-Antarctic islands, on Hawaii and elsewhere. Apart from founder effects, drift seems to be rare; the common assumption that mice live as persisting inbred demes is wrong. The population and genetical dynamics of Mus domesticus are much more complicated than is often believed.
DNA fingerprinting-a step forward in genetic monitoring

A A DEENY, B McDONALD
Technical Services Department, Harlan Olac Limited, Shaw's Farm, Blackthorn, Bicester, Oxon OX60TP, UK DNA fingerprinting is a new and valuable addition to the various methods that already exist for the authentication of inbred strains of animals. DNA fingerprinting was, until recently, limited in its use because of the necessity to use radiolabelled probes. However, the technique has been facilitated by the development of non-isotopic probes. A number of inbred strains for rats and mice have now been investigated using this method and their fingerprints collected. Variations between animals of the same strain from different sources and locations have been observed. Other methods of genetic monitoring do not necessarily detect such variations.
A mutant mouse strain, suspected of being contaminated, was investigated using biochemical markers.
The biochemical profile conformed to that published for the strain. However, when the DNA fingerprints were compared with animals of the same strain of known genetic authenticity, subtle differences were noted, implying that contamination had, indeed, occurred.
Whilst DNA fingerprinting is not a replacement for, but an addition to other monitoring methods, it is nevertheless a powerful technique enabling authentication of inbred strains at the molecular level.
Approaches to genetic monitoring of laboratory rats
H J HEDRICH Zentralinstitut fur Versuchstierzucht, ZFV Hermann-Ehlers-Allee 57, D-3000 Hannover 91, Germany Genetic monitoring of inbred strains should be a common practice for those who breed, maintain and supply laboratory rats. However, the approaches towards this goal are mostly biased by maintenance conditions, laboratory facilities and personal 141 preferences. Although there are no such agreements as to hygienic quality, any approach to genetic quality should start with the set-up of a genetic profile, including immunological, biochemical, morphological and, depending on the rat strains maintained, patho-physiOlogicaland/or cytogenetic markers and secondly an assessment of critical subset markers differentiating between strains maintained in the same unit. Once established these markers need to be tested at certain intervals to assure the integrity of the strains. It should be clear, however, that the measures required are to be adapted to specific needs, and depend on the scientific purpose, the physical maintenance conditions and the laboratory equipment (though this should not be the limiting factor). Nevertheless, it is of utmost importance to have an accurate colony management established.
We still need to face the situation that there are closely related strains which are difficult to differentiate and quite often there is a quest for authentication of certain animals with equivocal reactivity patterns after terminating a test -which to date in most cases has been impossible due to methodological problems. In these cases the demonstration of highly polymorphic stretches of repetitive DNA by PRC amplification using specific primers or by Southern blot analysis and hybridization with specific probes (DNA fingerprinting) will most probably provide the information being sought.
Neither DNA fingerprints nor PCR will substitute for an initial genetic profiling of either strain. These techniques are ideal for regular monitoring programmes and will be the method of choice to identify or authenticate suspect individuals.
Of man and beast-a study of immune relatedness J HAU
The Royal Veterinary College, University of London, Royal College Street, London NW1 OTU, UK In a rocket immunoelectrophoretic study commercially available antisera against human serum proteins were screened for their usability in the analysis of analogous proteins in a number of different species. Fortunately, evolutionary conservatism has resulted in common epitomes of many serum proteins between various mammalian species. It is well known that antisera against human proteins are applicable for the analysis of analogous proteins in closely related species such as primates. However, phylogenetically distant species frequently have epitopes (antigen determinants) in common with man, and consequently antisera raised against a human protein may often be used for qualitative and/or quantitative analysis of the corresponding animal protein.
The choice of genetic models for toxicology studies D P LOVELL BIBRA, Woodmansterne Road, Carshalton, Surrey SM54DS, UK Variability between individuals as a result of genetic differences can probably be found for any trait that is under investigation. Variation in the toxicological response to chemicals is no exception. Toxicological investigations have two main purposes; firstly to identify hazards as part of a safety evaluation process and, secondly, to determine the mechanisms underlying any toxicity detected and to assess the risk to the target species which is usually man. Genetic models can assist in both aspects of these investigations.
This presentation outlines the range of genetic variability that exists in responses to chemicals in rodents and how some of these relate to human responses. The potential of various genetic models such as inbred, congenic, recombinant inbred and mutant strains for studying toxicological responses are discussed by illustrating examples of their use. The longer-term potential of genetic models for assisting in investigating why some individuals have idiosyncratic reactions to chemicals are outlined. Finally, the potential of such models for reducing, refining and, in some cases, replacing the use of animals in toxicological studies is stressed.
The Harwell frozen embryo bank: a major genetic resource P H GLENISTER MRC Radiobiology Unit, Chilton, Didcot, Oxon
ORD, UK
After various feasibility studies on the effects of prolonged storage and the ability of various mutant stocks, inbred strains and stocks with chromosome anomalies to survive freezing and thawing, the Harwell frozen embryo bank was begun in 1976.
Today the bank contains 240 stocks including dominant and recessive mutations, Robertsonian translocations, reciprocal translocations and chromosome insertion and inversion stocks. Altogether, the genetics division of the Medical Research Council Radiobiology Unit at Harwell holds approximately 400 different stocks, so now more than 50070 of our strains are maintained solely in the frozen state. This represents an enormous increase in the range of stocks available to researchers both in this establishment and the rest of the world. With the advent of recombinant DNA technology and gene cloning it has been particularly valuable to be able to re-establish lines from the 12 albino and 20 pink-eye alleles held in the bank.
LASA Win:er meeting, 28-29 November 1991 When the bank was started, Mouse Genome (then Mouse news letter) listed about 500 mutants; today there are over 3300. It is envisaged that the bank will continue to grow both in size and importance during future years. Transgenic mice as model systems for studying gene mutations in vivo J A GOSSEN, W J F DE LEEUW, A BAKKER, J VIJG Medscand Ingen)', PO Box 685, 2300 AR Leiden, The Netherlands In recent years lTlanydifferent techniques have been developed to study the effects in man of exposure of somatic and germ cellsto carcinogens and/or mutagens. The adverse heallh effects, mainly tumour formation and induction of heritable diseases, cannot easily be monitored durini~the early stages since this requires systems capable 0:' detecting mutations occurring at very low frequency. By far the most information about in vivo somatic mutations comes from studies of the HPRT locus in lymphocytes. This method is based on 6thioguanine selection of HPRT-deficient T-lymphocyte cells from perip:leral blood. Disadvantages of this system for predicting the mutagenicity of compounds are that they are time-consuming, only a limited number of cell types can he analysed, and mutations observed may not always reflect mutation frequencies in the tissues of origin. fn vitro studies and long-term rodent studies also provide clues as to which carcinogens and mutagens may ccntribute to human cancer. The most extensively used in vitro assay for testing chemicals is the Ames Salmonella test. However, it has been shown that this assay has a sensitivity of only about 54% (percentage of carcinogens tested in the long-term rodent assay idemified as mutagens) and a specificity of only 700/0 (percertage of non-carcinogens identified as non-mutagens). Inclusion of three other in vitro shortterm assays (the mouse micro-nucleus assay, chromosome aberration! and sister chromatic exchanges) did not significantly improve the performance of in vitro assays for predi,;ting rodent carcinogenicity. Longterm rodent carcinogenicity studies however, are expensive, time-:onsuming and often conducted at near toxic doses, which does not reflect the low dose ranges where most human exposures occur.
Transgenic animal technology has recently been applied in developing improved mutagenesis testing systems. The approaches used include the use of shuttle vectors liarbouring a bacterial marker gene acting as a taqet for mutagenesis. Studies with transgenic mice on the mutagenicity of ethylnitrosourea have demonstrated that these systems are capable of detecting organ-specific and dose-dependent mutation frequencies in liver, brain, bone marrow, spleen and testis. As compared to in vitro assays, in vivo assays, like the transgenic mouse systems, more accurately account for the physiological and metabolic parameters that influence the mutagenic potential of a compound.
In order to further improve in vivo mutagenesis testing systems, a new transgenic mouse mutation model has been developed. The new model is based on the efficient rescue of LacZ containing plasmid vectors from geomic DNA, followed by introduction of the plasmids into an E. coli host strain. The latter allows easy identification of mutated vectors among large numbers of non-mutated vectors. The applicability and advantages of this model will be discussed.
Identification of mutagenic agents using transgenic mice containing a laci target gene D PUTMAN
Microbiological Associates Inc., Maryland, USA The identification of suspect mutagens is essential for regulating exposure to harmful agents. However, the ability to confirm or extend the findings of in vitro short-term mutagenesis assays with comparable in vivo test systems is limited. The majority of in vivo assays capable of detecting point mutations are costly, time-consuming, require large numbers of animals and are not extremely sensitive or easy to interpret. The use of shuttle vectors which permit transfer of DNA cells, has the potential to overcome many of the disadvantages of existing in vivo tests. This is made possible by the ability to monitor reporter genes, such as those controlling the expression of {3galactosidase, in which the presence of a mutation can be easily detected after transfer via the shuttle vector to a prokaryotic system. In addition to estimating the induced frequency of mutation, this technique allows direct correlation of the nucleic acid alteration to a particular mutagenic event. Mutations can be evaluated in both somatic and germ cells which will allow determination of tissue-specific mutagenesis.
Concerns for the welfare of transgenic animals T B POOLE
Universities Federation for Animal Welfare, 8 Hamilton Close, South Mimms, Potters Bar, Hertfordshire EN6 3QD, UK In the laboratory, the primary aim in producing transgenic animals is to investigate the mechanism of heredity. However, it is also possible, through 143 alteration of the genotype, to produce phenotypic or genotypic characteristics of interest to biomedical science. Where genetic material is from the same species, or the gene is biochemically identical, the resulting changes to the animal and their likely adverse effects can be assessed in a similar way to those of naturally occurring gene mutations. Alien genetic material, however, may also produce phenotypic effects which seriously compromise the welfare of the animal. In some instances the animal may suffer from disabilities or pathological conditions which resemble those occurring in human patients. However, where the proximal physiological causes in the transgenic animal are different, serious consideration should be given as to whether the model is scientifically valid.
Reductions in well-being may be acceptable where gene transfer is likely to increase our understanding of the mechanisms of heredity and development, or realistically simulates a specific pathological condition to be studied. Otherwise, transgenic animals should experience a quality of life similar to that of typical members of their species. Where there is any doubt, their quality of life can be assessed by veterinarians and ethologists.
Regulatory constraints on genetic manipulation of vertebrates C J ROBERTS
Home Office, Mansion House, Whitehall, Monkmoor Road, Shrewsbury, UK There are three broad areas of concern with genetic manipulation of vertebrates: the safety of people working with them, the possible harm to the environment consequent upon release, and the welfare of the animals themselves.
Under the Genetic Manipulation Regulations 1989, the Health and Safety Executive must be notified of work involving genetic manipulation. The risks of such work must be assessed using an approved method and a genetic manipulation committee set up to advise on these assessments. The Environment Protection Act 1990 contains specific provisions for the environmental safety of genetically modified organisms (GMO). These provisions are being put into effect through the GMO (Environmental Protection) Regulations 1992.
The Animals (Scientific Procedure) Act, 1986 controls all work on living vertebrates which may cause pain, suffering, distress or lasting harm. The definitions within the Act require control of procedures to insert DNA into the germline and subsequently to breed animals carrying the desired characteristic. Such work requires Project and Personal Licences under the Act and may be carried out only in establishments holding a Certificate of Designation.
Anybody presently contemplating work with genetically-modified vertebrates is advised to read ACGM/HSE Note 9 (available from the HSE) which contains a summary of the regulatory requirements.
Inbreeding of the Syrian hamster J C SALEN, K WORM, J HAU Laboratory Animal Science Unit, Department of Veterinary Pathology, The Royal Veterinary College, University of London, Royal Col/ege Street, London NW10TU A colony with two coisogenic inbred strains of the Syrian hamster (Meso cricetus auratus) has recently been developed at the Royal Veterinary and Agricultural University of Copenhagen, Denmark. The strains differ with respect to coat colour (pied grey/pied brown). Data on the reproductive performance during 20 generations of brother x sister mating will be presented and the extent of inbreeding depression subjected to discussion.
